Back
Tonix Pharmaceuticals Holding 10K Form
Sell
16
TNXP
Tonix Pharmaceuticals Holding
Last Price:
0.14
Seasonality Move:
7.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-13 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
| 2023-11-09 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
| 2023-08-10 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
| 2023-05-08 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
| 2022-11-07 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
| 2022-08-08 | 10Q | TNXP/Tonix Pharmaceuticals Holding Quarterly |
Receive TNXP News And Ratings
See the #1 stock for the next 7 days that we like better than TNXP
TNXP Financial Statistics
Sales & Book Value
| Annual Sales: | $7.77M |
|---|---|
| Cash Flow: | $-9.92M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.28 |
| Price / Book: | 0.07 |
Profitability
| EPS (TTM): | -98.51610 |
|---|---|
| Net Income (TTM): | $-149.01M |
| Gross Margin: | $3.03M |
| Return on Equity: | -144.09% |
| Return on Assets: | -119.36% |
Tonix Pharmaceuticals Holding Earnings Forecast
Key Tonix Pharmaceuticals Holding Financial Ratios
- The Gross Profit Margin over the past 16 years for TNXP is 38.97%.
- The Selling, General & Administrative Expenses for TNXP have been equal to 447.37% of Gross Profit Margin.
- The Research & Development expenses have been 1,115.54% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 16 years have been positive in 10 years.
Tonix Pharmaceuticals Holding Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TNXP |
| CUSIP: | 890260 |
| Website: | tonixpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 1.15 |
| Quick Ratio: | 0.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TNXP Technical Analysis vs Fundamental Analysis
Sell
16
Tonix Pharmaceuticals Holding (TNXP)
is a Sell
Is Tonix Pharmaceuticals Holding a Buy or a Sell?
-
Tonix Pharmaceuticals Holding stock is rated a Sell
The current Tonix Pharmaceuticals Holding [TNXP] share price is $0.14. The Score for TNXP is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.